Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Forex Boards
  25/11/2009
06:40:30
Site map		   Help
 
YM Biosciences Inc.
   
To register click here

YM Biosciences Stock Price YMI

YM Biosciences stock quote | YM Biosciences company information | YM Biosciences Stock Chart | YM Biosciences Stock News

Company Description : A biopharmaceutical company, which is engaged in the development of products for the treatment of patients with cancer. url: www.ymbiosciences.com

Name:
YM Biosciences Inc.		 Symbol:
AMEX:YMI		 Stock Market:
American Stock Exchange		 Type:
Equity		 ISIN:
 Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.00.001.21.01.274:15:11
stock Prices on this screen are 15 minutes delayed
To register Click hereRegister for free YM Biosciences stock prices.

YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA : MISSISSAUGA, ON, Nov. 23 /PRNewswire-FirstCall/ -- YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products...

Free YM Biosciences Stock Charts

YM Biosciences Historical Stock Chart
YM Biosciences Historical Stock Chart
YM Biosciences Monthly Stock Chart
YM Biosciences Monthly Stock Chart		YM Biosciences Intraday stock chart
YM Biosciences Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest YM Biosciences stock Price, quotes, trades and FREE YM Biosciences stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for YM Biosciences (YMI) and other American Stock Exchange listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

YM Biosciences News & Message Board Discussion

Latest YM Biosciences News Headlines
DateTimeSource
Headline
11/23/20095:00PMPRNUSYM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
11/18/200912:51PMPRNUSYM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
11/17/20097:00AMPRNUSYM BIOSCIENCES REPORTS CYT997 ORAL VASCULAR DISRUPTING AGENT RESULTS PRESENTED AT AACR-NCI-EORTC MEETING
11/11/20095:00PMPRNUSYM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
11/02/20092:08PMPRNUSYM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009
10/29/20095:30PMPRNUSYM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG
10/05/20096:29PMPRNUSYM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
09/25/20097:00AMPRNUSYM BIOSCIENCES REPORTS FISCAL YEAR END 2009 OPERATIONAL AND FINANCIAL RESULTS
09/17/20097:00AMPRNUSYM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO
08/10/20097:00AMPRNUSYM BIOSCIENCES USA RECEIVES CLEARANCE FROM US TREASURY DEPARTMENT TO EXTEND CLINICAL PROGRAM FOR NIMOTUZUMAB
06/29/20097:00AMPRNUSYM BIOSCIENCES' SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG
06/23/200911:48AMPRNUSYM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
Latest Message Board Discussions
DateTime
TitleMore
11/17/20099:41AM7:04AM YM BioSciences announces that preclinical results for
11/06/20099:08PMTranslation - Drug does work in this indication
11/05/20098:30AMYM BioSciences YMI Merriman started with a Buy
11/02/20095:06PM2:09PM YM BioSciences reports positive nimotuzumab four-year survival
10/29/20095:59PMYm Biosciences Reports Additional Results From Nimotuzumab Phase
10/28/20093:42PMBEST NEW ON ANY OF MY HOLDING IN MONTHS...
10/27/20094:23PMI feel your pain. I've SPPI that
10/27/20092:01PMwell considering it ran from about .4 to
10/27/20091:57PM[quote][i]I had expected a company with gov backing
10/27/20091:51PMWho can enlighten me with some time line

YM Biosciences Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest YM Biosciences company information and fundamental data for other USA Equity companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest YM Biosciences Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
      USD


 



s Stock Prices supplied by AMEX.
Free AMEX stock prices are delayed by at least s minutes. Realtime AMEX stock prices available.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
32 site:2us amex ymi091125 06:40 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )